×
For best experience we recommend to activate Javascript in your browser.
Phenylalanine Hydroxylase antibody (Center, Internal Region) (HRP)
The Rabbit Polyclonal anti-Phenylalanine Hydroxylase antibody has been validated for WB and ELISA. It is suitable to detect Phenylalanine Hydroxylase in samples from Human.
Quick Overview for Phenylalanine Hydroxylase antibody (Center, Internal Region) (HRP) (ABIN2329481)
Target
See all Phenylalanine Hydroxylase Antibodies
Phenylalanine Hydroxylase
Reactivity
All reactivities for Phenylalanine Hydroxylase antibodies
Human
Host
All hosts for Phenylalanine Hydroxylase antibodies
Rabbit
Clonality
All clonalities for Phenylalanine Hydroxylase antibodies
Polyclonal
Conjugate
All conjugates for Phenylalanine Hydroxylase antibodies
This Phenylalanine Hydroxylase antibody is conjugated to HRP
Application
All applications for Phenylalanine Hydroxylase antibodies
Western Blotting (WB), ELISA
Product Details anti-Phenylalanine Hydroxylase Antibody (HRP)
(hide)
Binding Specificity
All epitopes for Phenylalanine Hydroxylase antibodies
AA 140-170, Center, Internal Region
Cross-Reactivity
Human, Mouse (Murine)
Cross-Reactivity (Details)
Calculated cross reactivity: Hu Mo
Characteristics
PAH, ID (PAH, Phenylalanine-4-hydroxylase, Phe-4-monooxygenase) (Azide free) (HRP)
Purification
Purified by Protein A affinity chromatography.
Immunogen
PAH antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between amino acid 140-170 from the Central region of human PAH.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2. No preservative added (Azide free).
Preservative
Without preservative
Storage
-20 °C
Storage Comment
-20°C
Target Details for Phenylalanine Hydroxylase
(hide)
Target
Phenylalanine Hydroxylase
Alternative Name
PAH
Target Type
Chemical
UniProt
P00439
Recently viewed
(hide)
Chat with us , powered by LiveChat